A metabolic shift could also further lead to a reprogramming of B cells toward a phenotype with a higher pro-inflammatory propensity as suggested by a recent study where peripheral B cells from women with PCOS were shown to have an increased capacity to produce TNF-α, which is attenuated by metformin treatment (Xiao et al., 2022). This evidence concerns the gene TNF and polycystic ovary syndrome.